These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20824028)

  • 1. Bendamustine in Metastatic Breast Cancer: An Old Drug in New Design.
    Pirvulescu C; von Minckwitz G; Loibl S
    Breast Care (Basel); 2008; 3(5):333-339. PubMed ID: 20824028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New cytotoxic agents: a review of the literature.
    Hotta K; Ueoka H
    Crit Rev Oncol Hematol; 2005 Jul; 55(1):45-65. PubMed ID: 15927843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study.
    Eichbaum MH; Schuetz F; Khbeis T; Lauschner I; Foerster F; Sohn C; Schneeweiss A
    Anticancer Drugs; 2007 Sep; 18(8):963-8. PubMed ID: 17667603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metastatic breast cancer: what are the objectives?].
    Salvini P; Ripa C; Ginanni V
    Tumori; 2000; 86(5 Suppl 1):S22-8. PubMed ID: 11195289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capecitabine: a review.
    Walko CM; Lindley C
    Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine.
    Reichmann U; Bokemeyer C; Wallwiener D; Bamberg M; Huober J
    Ann Oncol; 2007 Dec; 18(12):1981-4. PubMed ID: 17872900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current combination chemotherapy regimens for metastatic breast cancer.
    Schwartz J
    Am J Health Syst Pharm; 2009 Dec; 66(23 Suppl 6):S3-8. PubMed ID: 19923317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I clinical trial of bendamustine and bevacizumab for patients with advanced cancer.
    Tsimberidou AM; Adamopoulos AM; Ye Y; Piha-Paul S; Janku F; Fu S; Hong D; Falchook GS; Naing A; Wheler J; Fortier A; Kurzrock R; Hess KR
    J Natl Compr Canc Netw; 2014 Feb; 12(2):194-203. PubMed ID: 24586081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
    Dennie TW; Kolesar JM
    Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bendamustine.
    Balfour JA; Goa KL
    Drugs; 2001; 61(5):631-8; discussion 639-40. PubMed ID: 11368287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to decrease taxanes toxicities in the adjuvant treatment of early breast cancer.
    Tang SC
    Cancer Invest; 2009 Feb; 27(2):206-14. PubMed ID: 19235594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxanes in breast cancer: an update.
    Conlin AK; Seidman AD
    Curr Oncol Rep; 2007 Jan; 9(1):22-30. PubMed ID: 17164044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ixabepilone as monotherapy or in combination with capecitabine for the treatment of advanced breast cancer.
    Rak Tkaczuk KH
    Breast Cancer (Auckl); 2011 Jan; 5():1-14. PubMed ID: 21494397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond.
    Esteva FJ; Valero V; Pusztai L; Boehnke-Michaud L; Buzdar AU; Hortobagyi GN
    Oncologist; 2001; 6(2):133-46. PubMed ID: 11306725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An old drug with a new future: bendamustine in multiple myeloma.
    Gentile M; Recchia AG; Mazzone C; Vigna E; Martino M; Morabito L; Lucia E; Bossio S; De Stefano L; Granata T; Palummo A; Morabito F
    Expert Opin Pharmacother; 2013 Nov; 14(16):2263-80. PubMed ID: 24053161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated administration of short infusions of bendamustine: a phase I study in patients with advanced progressive solid tumours.
    Schöffski P; Hagedorn T; Grünwald V; Paul H; Merkle K; Kowalski R; Ganser A
    J Cancer Res Clin Oncol; 2000 Jan; 126(1):41-7. PubMed ID: 10641748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bendamustine: rebirth of an old drug.
    Cheson BD; Rummel MJ
    J Clin Oncol; 2009 Mar; 27(9):1492-501. PubMed ID: 19224851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.